Literature DB >> 3628475

Influence of the enzyme induction by rifampicin on its presystemic metabolism.

U Loos, E Musch, J C Jensen, H K Schwabe, M Eichelbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3628475     DOI： 10.1016/0163-7258(87)90052-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  5 in total

1.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

2.  Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.

Authors:  K E Dooley; E E Bliven-Sizemore; M Weiner; Y Lu; E L Nuermberger; W C Hubbard; E J Fuchs; M T Melia; W J Burman; S E Dorman
Journal:  Clin Pharmacol Ther       Date:  2012-05       Impact factor: 6.875

Review 3.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

4.  A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients.

Authors:  Wynand Smythe; Akash Khandelwal; Corinne Merle; Roxana Rustomjee; Martin Gninafon; Mame Bocar Lo; Oumou Bah Sow; Piero L Olliaro; Christian Lienhardt; John Horton; Peter Smith; Helen McIlleron; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

5.  Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations.

Authors:  Muhammad F Rasool; Sundus Khalid; Abdul Majeed; Hamid Saeed; Imran Imran; Mohamed Mohany; Salim S Al-Rejaie; Faleh Alqahtani
Journal:  Pharmaceutics       Date:  2019-11-05       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.